Search Results - "Kramolowsky, Eugene V"

Quality of Life in the Phase 2/3 Trial of N-803 Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin‒Unresponsive Nonmuscle-Invasive Bladder Cancer by Chamie, Karim, Chang, Sam S, Kramolowsky, Eugene V, Gonzalgo, Mark L, Huang, Megan, Bhar, Paul, Spilman, Patricia, Sender, Lennie, Reddy, Sandeep K, Soon-Shiong, Patrick

“…INTRODUCTIONIn the phase 2/3 study QUILT-3.032 (NCT03022825), the ability of the IL-15RαFc superagonist N-803 (nogapendekin alfa inbakicept) plus bacillus…”
Get full text

Clinical variables and stone detection in patients with flank pain by Rapp, David E, Wood, Nada L, Bassignani, Matthew, Gergoudis, Luke, Caulkins, Sarah, Kramolowsky, Eugene V

“…Non-contrast CT (NCT) is commonly used to evaluate flank pain (FP). We sought to evaluate incidence of ureteral calculi on NCT in patients with FP, and to…”
Get more information

Providing Access to Care through a 24-Hour Dedicated Stone Line by Rapp, David E, Wood, Nada L, Wright, Jacob A, Booth, Brigette A, Colhoun, Andrew, Kramolowsky, Eugene V

“…INTRODUCTIONMany patients with urolithiasis are seen acutely in the emergency department for initial treatment. In an effort to improve cost and quality of…”
Get full text

Clinical and economic impact of implementation of slow shockwave lithotripsy for the treatment of urinary calculi by Kramolowsky, Eugene V, Wang, Grace, Butler, Ruth M, Wood, Nada L

“…To analyze the impact of slowing the shockwave delivery during extracorporeal shockwave lithotripsy (SWL) on the clinical patient outcome and the cost of…”
Get more information

Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15RαFc superagonist N-803 plus BCG by Chamie, Karim, Chang, Sam S., Kramolowsky, Eugene V., Gonzalgo, Mark L., Lechpammer, Stanislav, Reddy, Sandeep K., Soon-Shiong, Patrick

“…495 Background: Patients (pts) with BCG-unresponsive NMIBC have limited treatment options and are at an increased risk for cystectomy. Nogapendekin alfa…”
Get full text

Final clinical results of pivotal trial of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive CIS and papillary nonmuscle-invasive bladder cancer (NMIBC) by Chamie, Karim, Chang, Sam S., Gonzalgo, Mark, Kramolowsky, Eugene V., Sexton, Wade J., Bhar, Paul, Reddy, Sandeep K., Soon-Shiong, Patrick

“…4508 Background: Patients with NMIBC CIS unresponsive to BCG have limited treatment options. N-803 (Anktiva) is a mutant IL-15-based immunostimulatory fusion…”
Get full text

Positive efficacy and safety phase 3 results in both CIS and papillary cohorts BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) after IL-15RαFc superagonist N-803 (Anktiva) and BCG infusion by Chang, Sam S., Chamie, Karim, Gonzalgo, Mark L., Kramolowsky, Eugene V., Sexton, Wade J., Reddy, Sandeep K., Bhar, Paul, Huang, Megan, Soon-Shiong, Patrick

“…Abstract only 431 Background: N-803, a high affinity IL-15 immunostimulatory fusion protein promotes proliferation and activation of natural killer (NK) cells…”
Get full text

Phase II/III clinical results of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) carcinoma in situ (CIS) patients by Chamie, Karim, Chang, Sam, Gonzalgo, Mark L., Kramolowsky, Eugene V., Sexton, Wade J., Reddy, Sandeep K., Bhar, Paul, Garner, Chad, Soon-Shiong, Patrick

“…Abstract only 510 Background: Patients with NMIBC CIS unresponsive to BCG have limited treatment options. N-803 (Anktiva) is a mutant IL-15-based…”
Get full text

A phase II clinical study of intravesical photo dynamic therapy in patients with BCG-unresponsive NMIBC (interim analysis) by Kulkarni, Girish S., Richards, Kyle A, Black, Peter C., Rendon, Ricardo A., Chin, Joseph, Shore, Neal D., Jayram, Gautam, Kramolowsky, Eugene V., Saltzstein, Daniel, Agarwal, Piyush K., Belkoff, Laurence, O'Donnell, Michael A., Kamat, Ashish M., Jewett, Michael A.S., Lamm, Donald L., DeGruttola, Victor, Mandel, Arkady, Dumoulin-White, Roger, Kassouf, Wassim

“…528 Background: Novel therapies are required for BCG-unresponsive, high risk non-muscle invasive bladder cancer. We report the interim results of a Phase II…”
Get full text

Quality of Life in the Phase 2/3 Trial of N-803 Plus BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer by Chamie, Karim, Chang, Sam S, Kramolowsky, Eugene V, Gonzalgo, Mark L, Huang, Megan, Bhar, Paul, Spilman, Patricia, Sender, Lennie, Reddy, Sandeep K, Soon-Shiong, Patrick

“…In the phase 2/3 study QUILT 3.032 (NCT03022825), the ability of the IL-15RαFc superagonist N-803 (nogapendekin alfa inbakicept or NAI) plus bacillus…”
Get full text

Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer by Hart, Stacey L., Latini, David M., Cowan, Janet E., Carroll, Peter R.

“…Goals of work Fear of cancer recurrence (FOR) is common in prostate cancer patients, but little research has examined the impact of FOR on quality of life…”
Get full text

Color Doppler ultrasound for the diagnosis of segmental testicular infarction by Kramolowsky, E V, Beauchamp, R A, Milby, 3rd, W P

“…We report a case of segmental infarction of the testis associated with scrotal pain diagnosed by color Doppler ultrasound. Histological examination of the…”
Get more information

Education predicts quality of life among men with prostate cancer cared for in the department of veterans affairs : A longitudinal quality of life analysis from CaPSURE by KNIGHT, Sara J, LATINI, David M, HART, Stacey L, SADETSKY, Natalia, KANE, Christopher J, DUCHANE, Janeen, CARROLL, Peter R

“…Previous findings have suggested that patient educational attainment is related to cancer stage at presentation and treatment for localized prostate cancer,…”
Get full text

Clinical efficacy of combined lithoclast and lithovac stone removal during ureteroscopy by Delvecchio, F C, Kuo, R L, Preminger, G M

“…Pneumatic lithotripsy has proved to be an extremely safe, efficient and low cost intracorporeal fragmentation modality. Unfortunately proximal migration of…”
Get more information

The value of testosterone deprivation in stage D1 carcinoma of the prostate by Kramolowsky, E V

“…The question of whether hormonal manipulation is effective in the treatment of stage D1 carcinoma of the prostate has yet to be determined conclusively. To…”
Get more information

Ureteral perforation during ureterorenoscopy: treatment and management by Kramolowsky, E V

“…Ureterorenoscopy has become a popular diagnostic and therapeutic tool for the modern urologist but this procedure is not without complications and risks. The…”
Get more information

The urological application of electrosurgery by Kramolowsky, E V, Tucker, R D

Get more information

Endourological treatment of ureteroenteric anastomotic strictures: long-term followup by Meretyk, S, Clayman, R V, Kavoussi, L R, Kramolowsky, E V, Picus, D D

“…In 1987 we reported our initial experience with an endosurgical incisional approach to ureteroenteric anastomotic strictures (that is endoureterotomy). We have…”
Get more information

Management of ureterointestinal anastomotic strictures: comparison of open surgical and endourological repair by Kramolowsky, E V, Clayman, R V, Weyman, P J

“…The established treatment for ureterointestinal anastomotic strictures is open surgical revision. In an effort to evaluate the efficacy of endourological…”
Get more information

Impact of physician awareness on hospital charges for radical retropubic prostatectomy by Kramolowsky, E V, Wood, N L, Rollins, K L, Glasheen, W P, Nelson, C M

“…We determine if physician awareness of hospital costs for radical retropubic prostatectomy affects physician practice patterns. We reviewed 256 consecutive…”
Get more information